Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies

被引:10
作者
Almeida, JI [1 ]
Liem, TK [1 ]
Silver, D [1 ]
机构
[1] Univ Missouri, Dept Surg, Columbia, MO 65212 USA
关键词
D O I
10.1016/S0741-5214(98)70270-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Thromboresistant synthetic grafts should decrease the frequency of graft thromboses and could be useful in bypasses to small arteries and to arteries with compromised flow. Heparin-bonded grafts (HBG) have been developed. Studies were done to determine whether the heparin bond is permanent and whether the HBG would aggregate platelets in the presence of heparin-associated antiplatelet antibodies (HAAbs). Methods: We studied an 8 mm HBG from company A (HBGA) and 8 mm and 6 mm HBGs from company B (HBGB-8 and HBGB-6), none of which is available for clinical use in the United States. Five 1 cm long segments of HBGA, HBGB-8, and HBGB-6 were incubated for 24 hours in 5 mi of plasma, 10 mi of saline, or 10 mi of Ringer's lactate. After incubation, I mi was obtained from each solution and assayed for heparin. Segments of each graft that leached off an equivalent of 1 U of heparin/ml (i.e., 1 mm(2) of HBGA, 5 mm(2) of HBGB-8, and 20 mm(2) of HBGB-6) were incubated with 0.15 mi of plasma with HAAbs (Six samples per graft) for 30 minutes at 25 degrees C. The grafts were removed, and 0.1 mi of normal-donor, platelet-rich plasma was added, The samples were placed im an aggregometer and allowed to react until positive aggregation occurred or 27 minutes had elapsed. Segments of non-heparin-bonded polyester grafts served as controls. Results: Heparin leached off all grafts in plasma (mean values: HBGA, 83.4 U of heparin/ml; HBGB-8, 4 U of heparin/ml; HBGB-6, 6.2 U of heparin/ml), In normal saline, the mean heparin concentrations were lower (HBGA, 10.8 U of heparin/ml; HBGB-8, 0 U of heparin/ml; HBGB-6, 0.01 U of heparin/ml. The mean heparin concentration after incubation in Ringer's lactate were 10 U of heparin/ml for HBGA, 0 U of heparin/ml HBGB-8, and 0.22 U of heparin/ml HBGB-6. All of the HBGs induced platelet aggregation inHAAb-positive plasma. None of the control grafts induced platelet aggregation in HAAb-positive plasma. Conclusions: All HBGs leeched heparin into plasma, and all induced platelet aggregation in the presence of HAAbs, The possibility of sensitizing patients to heparin leeching from a HBG with the activation of platelets and secondary thrombosis strongly suggests that HBG be used with great caution. Other methods for inducing graft thromboresistance should be developed.
引用
收藏
页码:896 / 901
页数:6
相关论文
共 13 条
[1]   DURABILITY OF VEIN GRAFT REVISION - THE OUTCOME OF SECONDARY PROCEDURES [J].
BANDYK, DF ;
BERGAMINI, TM ;
TOWNE, JB ;
SCHMITT, DD ;
SEABROOK, GR .
JOURNAL OF VASCULAR SURGERY, 1991, 13 (02) :200-210
[2]  
ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
[3]  
ESQUIVEL CO, 1984, SURGERY, V95, P102
[4]  
GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
[5]  
KAPSCH D, 1981, ARCH SURG-CHICAGO, V116, P1423
[6]   A NEW NON-THROMBOGENIC SURFACE PREPARED BY SELECTIVE COVALENT BINDING OF HEPARIN VIA A MODIFIED REDUCING TERMINAL RESIDUE [J].
LARM, O ;
LARSSON, R ;
OLSSON, P .
BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS, 1983, 11 (2-3) :161-173
[7]   HEPARIN-COATED CATHETERS AND HEPARIN-INDUCED THROMBOCYTOPENIA [J].
LASTER, J ;
SILVER, D .
JOURNAL OF VASCULAR SURGERY, 1988, 7 (05) :667-672
[8]   BIOLOGICALLY-ACTIVE HEPARIN COATING IN MEDICAL DEVICES [J].
OLSSON, P ;
LARM, O .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (08) :453-456
[9]  
ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
[10]   CONTROL OF CONTACT ACTIVATION ON END-POINT IMMOBILIZED HEPARIN - THE ROLE OF ANTITHROMBIN AND THE SPECIFIC ANTITHROMBIN-BINDING SEQUENCE [J].
SANCHEZ, J ;
ELGUE, G ;
RIESENFELD, J ;
OLSSON, P .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (05) :655-661